Bottom line
IQLT vs GIIAX: the short answer
IQLT (iShares MSCI Intl Quality Factor ETF) and GIIAX (Nationwide International Index Fund) are both etfs.
But GIIAX is far broader, holding 693 positions to 320 for IQLT, so beyond the top names it adds exposure IQLT doesn't have.
IQLT is cheaper at 0.3% vs 0.69% — a difference of $39 a year per $10,000 invested.
Over five years, GIIAX returned +7.1% a year vs +5.5% for IQLT (reporting dates differ).
GIIAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
IQLT vs GIIAX side by side
| IQLT | GIIAX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | iShares | Nationwide |
| Category | International Stock | International Stock |
| Expense ratio | 0.3% | 0.69% |
| Annual cost per $10k | $30 | $69 |
| 10-yr cost on $10k (prospectus) | $381 | $1,457 |
| Max front load | None | 5.75% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +1.7% | +23.5% |
| 5-yr return (annualized) | +5.5% | +7.1% |
| 10-yr return (annualized) | +6.4% | +7.1% |
| Best quarter | +17.8% | +18.3% |
| Worst quarter | −19.5% | −22.8% |
| Net assets (fund) | $13.8B | $910.2M |
| Number of holdings | 320 | 693 |
| Portfolio turnover | 2% | 13% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IQLT | GIIAX | Difference |
|---|---|---|---|
| 2024 | +1.7% | +2.9% | −1.2% |
| 2023 | +18.5% | +17.0% | +1.4% |
| 2022 | −15.1% | −14.4% | −0.7% |
| 2021 | +12.8% | +10.6% | +2.2% |
| 2020 | +13.1% | +7.3% | +5.9% |
| 2019 | +27.8% | +21.5% | +6.3% |
| 2018 | −10.9% | −14.1% | +3.2% |
| 2017 | +24.1% | +24.7% | −0.7% |
| 2016 | +0.6% | +0.6% | +0.0% |
Source: Fund prospectus bar charts
Holdings overlap
12 of IQLT's top 25 holdings also appear in GIIAX's top 25.
| Holding | IQLT | GIIAX |
|---|---|---|
| ASML Holding N.V. | 5.42% | 2.86% |
| Allianz SE | 2.68% | 0.85% |
| Roche Holding AG | 2.20% | 1.38% |
| ABB Ltd | 1.95% | 0.70% |
| Nestle S.A. | 1.81% | 1.16% |
| Novartis AG | 1.78% | 1.29% |
| Astrazeneca Plc | 1.68% | 1.16% |
| Shell Plc | 1.59% | 1.16% |
| Rolls-royce Holdings Plc | 1.50% | 0.75% |
| Schneider Electric Se | 1.43% | 0.83% |
| Totalenergies Se | 1.32% | 0.79% |
| Novo Nordisk A/s | 1.12% | 0.68% |
Source: SEC Form N-PORT
IQLT top 10
- ASML Holding N.V. — 5.42%
- Allianz SE — 2.68%
- Roche Holding AG — 2.20%
- ABB Ltd — 1.95%
- Zurich Insurance Group AG — 1.83%
- Nestle S.A. — 1.81%
- Novartis AG — 1.78%
- Astrazeneca Plc — 1.68%
- Advantest Corporation — 1.65%
- Shell Plc — 1.59%
GIIAX top 10
- ASML Holding NV — 2.86%
- HSBC Holdings plc — 1.66%
- Roche Holding AG — 1.38%
- Novartis AG — 1.29%
- AstraZeneca plc — 1.16%
- Shell plc — 1.16%
- Nestle SA — 1.16%
- Siemens AG — 1.09%
- Mitsubishi UFJ Financial Group, Inc. — 1.08%
- BHP Group Ltd. — 0.97%
FAQ
What is the difference between IQLT and GIIAX?
Which is cheaper, IQLT or GIIAX?
Should I own both IQLT and GIIAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.